Ogata et al. demonstrated through reverse transcription polymerase chain reaction (RT-PCR) and immunohistochemical (IHC) analysis that many human CRCs produce CXCL1, and that CXCR2 mRNA is present in all tested CRC lines [74]. This evidence concerns the gene CXCR2 and colorectal carcinoma.